CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 136,941	$ 188,231
Restricted cash and equivalents	1,682	5,629
Marketable securities	230,143	211,737
Receivables, net	1,239,603	1,017,040
Prepaid expenses and other current assets, net	42,353	35,137
Total current assets	1,650,722	1,457,774
Property and equipment, net	28,088	28,169
Intangible assets, net	68,187	72,771
Goodwill	24,133	24,133
Other assets	161,731	151,136
Total assets	1,932,861	1,733,983
Current liabilities:
Medical claims and related payables	1,113,084	931,664
Accounts payable and accrued expenses	226,693	220,342
Current debt	34,924	0
Total current liabilities	1,374,701	1,152,006
Long-term debt	0	34,904
Other liabilities	57,906	76,121
Total liabilities	1,432,607	1,263,031
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 413,023 and 412,194 shares issued and outstanding, respectively	4,130	4,122
Additional paid-in capital	2,070,446	2,053,895
Accumulated deficit	(1,574,865)	(1,586,977)
Accumulated other comprehensive income (loss)	543	(88)
Total stockholders’ equity (deficit)	500,254	470,952
Total liabilities and stockholders’ equity (deficit)	$ 1,932,861	$ 1,733,983